Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Dangoor

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective studyToby Talbot, Adam Dangoor, Riyaz Shah, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2009
Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4)Eyad Elkord, Adam Dangoor, Deborah J Burt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 4, 2008
An MVA-based vaccine targeting the oncofetal antigen 5T4 in patients undergoing surgical resection of colorectal cancer liver metastasesEyad Elkord, Adam Dangoor, Noel L Drury, et al.
Trials|August 31, 2018
Zoledronic acid in the management of mesothelioma - a feasibility study (Zol-A Trial): study protocol for a randomised controlled trialDuneesha de Fonseka, Anna Morley, Louise Stadon, et al.
Health Technology Assessment (Winchester, England)|June 5, 2026
Treatments for metastatic non-small cell lung cancer: a pathways pilot with systematic review, evidence synthesis and economic modelHugo Pedder, Catalina Lopez Manzano, Lindsay Claxton, et al.
The Lancet. Oncology|June 5, 2019
Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trialIan Judson, James P Morden, Lucy Kilburn, et al.
Nature|September 5, 2020
Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancerGary Middleton, Peter Fletcher, Sanjay Popat, et al.
Nature|July 17, 2020
The National Lung Matrix Trial of personalized therapy in lung cancerGary Middleton, Peter Fletcher, Sanjay Popat, et al.
Ecancermedicalscience|February 26, 2016
An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patientsRichard Baird, Ian Banks, David Cameron, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective studyToby Talbot, Adam Dangoor, Riyaz Shah, et al.
Cancer Immunology, Immunotherapy : CII|February 18, 2009
Immune evasion mechanisms in colorectal cancer liver metastasis patients vaccinated with TroVax (MVA-5T4)Eyad Elkord, Adam Dangoor, Deborah J Burt, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 4, 2008
An MVA-based vaccine targeting the oncofetal antigen 5T4 in patients undergoing surgical resection of colorectal cancer liver metastasesEyad Elkord, Adam Dangoor, Noel L Drury, et al.
Trials|August 31, 2018
Zoledronic acid in the management of mesothelioma - a feasibility study (Zol-A Trial): study protocol for a randomised controlled trialDuneesha de Fonseka, Anna Morley, Louise Stadon, et al.
Health Technology Assessment (Winchester, England)|June 5, 2026
Treatments for metastatic non-small cell lung cancer: a pathways pilot with systematic review, evidence synthesis and economic modelHugo Pedder, Catalina Lopez Manzano, Lindsay Claxton, et al.
The Lancet. Oncology|June 5, 2019
Cediranib in patients with alveolar soft-part sarcoma (CASPS): a double-blind, placebo-controlled, randomised, phase 2 trialIan Judson, James P Morden, Lucy Kilburn, et al.
Nature|September 5, 2020
Publisher Correction: The National Lung Matrix Trial of personalized therapy in lung cancerGary Middleton, Peter Fletcher, Sanjay Popat, et al.
Nature|July 17, 2020
The National Lung Matrix Trial of personalized therapy in lung cancerGary Middleton, Peter Fletcher, Sanjay Popat, et al.
Ecancermedicalscience|February 26, 2016
An Association of Cancer Physicians' strategy for improving services and outcomes for cancer patientsRichard Baird, Ian Banks, David Cameron, et al.
Pageof 2